GSK wins Japan approval for Hibsago hepatitis B treatment
GSK Plc said Japan's Ministry of Health, Labour and Welfare approved Hibsago, bepirovirsen, as a functional cure for chronic hepatitis B virus infections in adult patients who have received at least six months of prior nucleos ide...
GSK Plc on Monday reported two positive regulatory developments for its treatments of hepatitis and rectal cancer.
Japan's Ministry of Health, Labour& Welfare has approved Hibsago, whose generic name is bepirovirsen, as a functional cure for chronic hepatitis B virus infections "in adult patients who have received at least six months of prior nucleos ide... (Alliance News) - GSK Plc on Monday reported two positive regulatory developments for its treatments of hepatitis and rectal cancer.